Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ceftriaxone neonatal therapy and hyperbilirubinemia trial
2011-004417-16Phase 4
- Sponsor
- St. Elisabeth-Hospital
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ceftriaxone in bacterial disease (2 arms), sponsored by St. Elisabeth-Hospital. Primary endpoint: Incidence of hyperbilirubinemia.
02
Drugs
ceftriaxone
03
Conditions
bacterial disease
Beyond the preview
Go deeper on 2011-004417-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004417-16.